Literature DB >> 30392334

[A long journey of cervical cancer prevention in China].

Y L Qiao1.   

Abstract

Cervical cancer is the fourth most common cancer in women worldwide. More than 80% of cervical cancer deaths occur in low- and middle-income countries. Global health faces enormous challenges. Prevention and control of cervical cancer have a promising prospect, owing to the etiology of carcinogenesis being clearly understood, great efficacy of HPV prophylactic vaccine being proved, technologies of early detection and treatment being well-established, and the various screening strategies being available for communities with different social and economic status. In this commentary, we focused on China and discussed the challenges and opportunities faced by the grass-roots hospitals and clinics, considering the large population load in China and unbalanced allocation of scarce healthcare resources across the nation. In the framework of "Healthy China 2030" , much needs to be done to prevent and control cervical cancer in the upcoming 12 years.

Entities:  

Keywords:  Human papillomavirus; Prevention; Screening; Uterine cervical neoplasms; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 30392334     DOI: 10.3760/cma.j.issn.0253-3766.2018.10.001

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  3 in total

1.  Proposing a novel care program: reminiscence therapy involved care for anxiety, depression, and quality of life in postoperative cervical cancer patients.

Authors:  Xiaojing Liu; Kun Yuan; Xuekui Ye; Rui Liu
Journal:  Ir J Med Sci       Date:  2021-10-30       Impact factor: 2.089

2.  Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.

Authors:  Li Liu; Yumei Chen; Qingyuan Zhang; Changzhong Li
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

3.  Prevalence and type distribution of human papillomavirus in a Chinese urban population between 2014 and 2018: a retrospective study.

Authors:  Mei-Yan Xu; Bing Cao; Yan Chen; Juan Du; Jian Yin; Lan Liu; Qing-Bin Lu
Journal:  PeerJ       Date:  2020-03-23       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.